Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2019-08-01
DOI
10.1080/21645515.2019.1649532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Ebola Virus Vaccine Progress
- (2019) Andrea Marzi et al. BIODRUGS
- Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak
- (2019) L. E. Kafetzopoulou et al. SCIENCE
- Schistosoma mansoni rSm29 Antigen Induces a Regulatory Phenotype on Dendritic Cells and Lymphocytes From Patients With Cutaneous Leishmaniasis
- (2019) Diego Mota Lopes et al. Frontiers in Immunology
- A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection
- (2019) Xiaodan Shi et al. VIROLOGICA SINICA
- Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus
- (2019) Fangfang Dong et al. npj Vaccines
- A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs
- (2019) Derek R. Stein et al. npj Vaccines
- Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus – Zaire Ebolavirus Vaccine
- (2019) Masumbuko Claude Kasereka et al. VACCINE
- Phycobilisomes Harbor FNRL in Cyanobacteria
- (2019) Haijun Liu et al. mBio
- Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever
- (2019) Sergio E. Rodriguez et al. Scientific Reports
- A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization
- (2018) Renqiang Liu et al. ANTIVIRAL RESEARCH
- Rhabdoviruses as vaccine platforms for infectious disease and cancer
- (2018) Franz Zemp et al. Biotechnology & Genetic Engineering Reviews
- Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination
- (2018) Lise Gross et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The group I alphabaculovirus-specific protein, AC5, is a novel component of the occlusion body but is not associated with ODVs or the PIF complex
- (2018) Xi Wang et al. JOURNAL OF GENERAL VIROLOGY
- Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
- (2018) Courtney Woolsey et al. JOURNAL OF INFECTIOUS DISEASES
- Systems modelling tools to support policy and planning
- (2018) Jo-An Atkinson et al. LANCET
- Ebola virus disease: an update on post-exposure prophylaxis
- (2018) William A Fischer et al. LANCET INFECTIOUS DISEASES
- Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study
- (2018) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Post-exposure treatments for Ebola and Marburg virus infections
- (2018) Robert W. Cross et al. NATURE REVIEWS DRUG DISCOVERY
- Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia
- (2018) Eva Ferreras et al. NEW ENGLAND JOURNAL OF MEDICINE
- A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections
- (2018) Anasuya Chattopadhyay et al. VACCINE
- Structural absorption by barbule microstructures of super black bird of paradise feathers
- (2018) Dakota E. McCoy et al. Nature Communications
- A VSV-based Zika virus vaccine protects mice from lethal challenge
- (2018) Jackson Emanuel et al. Scientific Reports
- Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
- (2018) Myoung-don Oh et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial
- (2018) Marnie L. Elizaga et al. PLoS One
- Current research for a vaccine against Lassa hemorrhagic fever virus
- (2018) Bryce M Warner et al. Drug Design Development and Therapy
- The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses
- (2018) Tracey Goldstein et al. Nature Microbiology
- Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans
- (2018) Joseph H Poetsch et al. JOURNAL OF INFECTIOUS DISEASES
- Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity
- (2017) Dillon Betancourt et al. JOURNAL OF IMMUNOLOGY
- Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
- (2017) Scott A. Halperin et al. JOURNAL OF INFECTIOUS DISEASES
- Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge
- (2017) Demetrius Matassov et al. JOURNAL OF VIROLOGY
- Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain
- (2017) Anthony N. van den Pol et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial
- (2017) Michelle J Groome et al. LANCET INFECTIOUS DISEASES
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
- (2017) Stephen B. Kennedy et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa
- (2017) Angela Huttner et al. Science Translational Medicine
- Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic
- (2017) Beth-Ann G. Coller et al. VACCINE
- Ebola and Marburg virus vaccines
- (2017) Pierce Reynolds et al. VIRUS GENES
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV
- (2017) Anne Rechtien et al. Cell Reports
- Vaccines for epidemic infections and the role of CEPI
- (2017) Stanley A. Plotkin Human Vaccines & Immunotherapeutics
- Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service
- (2017) Angela Hamblin et al. PLOS MEDICINE
- Nubia’s mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola
- (2017) Séverine Caluwaerts Reproductive Health
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
- (2017) Christine Dahlke et al. EBioMedicine
- Use of Postexposure Prophylaxis After Occupational Exposure toZaire ebolavirus
- (2016) Karen K. Wong et al. CLINICAL INFECTIOUS DISEASES
- Zika virus: a previously slow pandemic spreads rapidly through the Americas
- (2016) Derek Gatherer et al. JOURNAL OF GENERAL VIROLOGY
- Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia
- (2016) Chaturaka Rodrigo et al. JOURNAL OF INFECTIOUS DISEASES
- Unique human immune signature of Ebola virus disease in Guinea
- (2016) Paula Ruibal et al. NATURE
- A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
- (2016) Kayvon Modjarrad et al. NATURE MEDICINE
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-time stability of a hepatitis E vaccine (Hecolin®) demonstrated with potency assays and multifaceted physicochemical methods
- (2016) Xiao Zhang et al. VACCINE
- Production of Plasmodium vivax enolase in Escherichia coli and its protective properties
- (2016) Chao Zhang et al. Human Vaccines & Immunotherapeutics
- Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine
- (2016) Blair L DeBuysscher et al. npj Vaccines
- Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine
- (2016) Fouzia Farooq et al. Scientific Reports
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick
- (2015) Lilin Lai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
- (2015) Demetrius Matassov et al. JOURNAL OF INFECTIOUS DISEASES
- Stability of a Vesicular Stomatitis Virus–Vectored Ebola Vaccine
- (2015) Marianne Arnemo et al. JOURNAL OF INFECTIOUS DISEASES
- Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
- (2015) Emmanuelle Le Page et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- First report of autochthonous transmission of Zika virus in Brazil
- (2015) Camila Zanluca et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
- (2015) Chad E. Mire et al. NATURE
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease
- (2015) Joseph Prescott et al. VACCINE
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
- (2015) Jonathan D. Fuchs et al. Open Forum Infectious Diseases
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
- (2014) Chad E. Mire et al. PLoS One
- Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins
- (2014) Blair L. DeBuysscher et al. VACCINE
- Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
- (2014) Joseph Prescott et al. Viruses-Basel
- Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters
- (2013) Michael K. Lo et al. ANTIVIRAL RESEARCH
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
- (2013) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- A Chimeric Vesiculo/Alphavirus Is an Effective Alphavirus Vaccine
- (2012) A. Chattopadhyay et al. JOURNAL OF VIROLOGY
- Protective Efficacy of a Bivalent Recombinant Vesicular Stomatitis Virus Vaccine in the Syrian Hamster Model of Lethal Ebola Virus Infection
- (2011) Yoshimi Tsuda et al. JOURNAL OF INFECTIOUS DISEASES
- Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus
- (2011) Darryl Falzarano et al. JOURNAL OF INFECTIOUS DISEASES
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus
- (2011) K. S. Brown et al. JOURNAL OF VIROLOGY
- A single amino acid mutation alters the capsid protein electrophoretic double-band phenotype of the Plum pox virus strain PPV-Rec
- (2010) Z. W. Šubr et al. ARCHIVES OF VIROLOGY
- Complementing Defective Viruses That Express Separate Paramyxovirus Glycoproteins Provide a New Vaccine Vector Approach
- (2010) A. Chattopadhyay et al. JOURNAL OF VIROLOGY
- Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus Infection
- (2010) Thomas W. Geisbert et al. PLoS One
- A Kaposi's Sarcoma-Associated Herpesvirus Protein That Forms Inhibitory Complexes with Type I Interferon Receptor Subunits, Jak and STAT Proteins, and Blocks Interferon-Mediated Signal Transduction
- (2009) S. A. Bisson et al. JOURNAL OF VIROLOGY
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
- (2009) Xiangguo Qiu et al. PLoS One
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- (2008) Thomas W. Geisbert et al. VACCINE
- Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01
- (2008) Arun V. Iyer et al. VACCINE
- SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector
- (2008) Sagar U. Kapadia et al. VIROLOGY
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search